Stem Cell Source Market 2021 Size, Growth Analysis Report, Forecast to 2027

The global stem cell source market is expected to grow at a significant CAGR during the forecast period (2021-2027). The growing use of stem cells in regenerative medicine is driving the market growth. The rise in the number of chronic diseases such as heart disease, diabetes, cancer, and others globally is driving market growth. According to Heart Research institute UK, over the age of 40 people with general good health have 50% chance of developing serious Atherocerosis, which is a kind of heart disease. According to the Diabetic Community of the UK, there were 415 million diabetics patient globally in 2019. Regenerative medicines are generated with stem cells to restore damaged tissue and are used to treat a variety of ailments. The increased number of clinical trials for regenerative medicines, as well as the advancement of stem cell-based therapeutics, is creating opportunities for market participants. According to Change.org, Inc., 64% of Americans support federal financing for chronic disease research with stem cells derived from human embryos. Internationally, major government investments in stem cell research are being made, with Asia being one of the most suitable regions. The National Institutes of Health (NIH) has increased its funding for stem cell research in recent years.

To Request a Sample of our Report on Stem Cell Source Market: https://www.omrglobal.com/request-sample/stem-cell-source-market

In addition, increase in stem cell banking services is expected to boost the market growth. The umbilical cord blood contains a pool of hematopoietic and mesenchymal stem cells that can be retained for eventual use after childbirth. Hematological disease such as leukaemia, lymphoma, and sickle cell anaemia can all be treated with preserved blood. The expense of storage is significant, and the American Academy of Pediatrics estimates that 1 in 1,000 people will require cord blood stem cells. Nonetheless, parents choose storage, and over 20,000 people in the US have undergone some kind of surgeries which used the stored umbilical cord blood.

The key companies operating in the industry are highly inclined towards the adoption of different growth strategies including partnerships and collaborations, mergers and acquisitions, geographical expansion, new product launches, to remain competitive in the marketplace. For instance, in March 2021, OrganaBio released the HematoPAC ASC-cb CD34 hematopoietic stem cell product in order to support HSC-based allogeneic cell therapy.

Market Coverage

• The market number available for - 2020-2027

• Base year- 2020

• Forecast period- 2021-2027

Segment Covered-

· By Type

· By Application

Regions covered-

· North America

· Europe

· Asia-Pacific

· Rest of the World

Competitive Landscape: BD Biosciences, Thermo Fisher Scientific, Inc., and Merck KGaA, among others.

(Get 15% Discount on Buying this Report)

A full Report of Stem Cell Source Market is Available @ https://www.omrglobal.com/industry-reports/stem-cell-source-market

Global Stem Cell Source Market Report by Segment

By Type

· Bone Marrow

· Blood

· Others

By Application

· Regenerative Medicines

· Drug Discovery and Development

Global Stem Cell Source Market Report by Region

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

· Latin America

· Middle East & Africa

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.